Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Rhabdomyosarcoma 8Wilms Tumor 6Sarcoma 6Malignant mesenchymal tumor 4Rhabdomyosarcoma, Embryonal 2Kidney Neoplasms 2Hydatidiform Mole 2Stage I Mixed Cell Type Kidney Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1Pleuropulmonary blastoma 1Gestational Trophoblastic Disease 1Fibrosarcoma 1Choriocarcinoma 1Carcinoma, Renal Cell 1Beckwith-Wiedemann Syndrome 1

Interventions

Ifosfamide 8Doxorubicin 7Filgrastim 3brostallicin 2Trabectedin 2Radiotherapy, Conformal 2Imatinib Mesylate 2perifosine 1pegfilgrastim 1indolepropanol phosphate 1exatecan 1etoposide phosphate 1X-Rays 1Watchful Waiting 1Vincristine 1Radiotherapy 1Observation 1Mesna 1Mass Spectrometry 1Granulocyte Colony-Stimulating Factor 1Glutamine 1Etoposide 1Dactinomycin 1Cyclophosphamide 1Combined Modality Therapy 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1Biopsy 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Fibrosarcoma × Dactinomycin × Clear all
NCT00072280 2014-09-30

Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma

Children's Oncology Group

Phase 2 Terminated
7 enrolled 9 charts
Sarcoma

Fibrosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡